Ownership history in Kynam Capital Management, LP · 18 quarters on record
This page tracks every 13F SEC filing in which Kynam Capital Management, LP reported a position in CELLDEX THERAPEUTICS INC NEW (CLDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 5,943,180 | -157,549 | -2.6% | 10.31% | $161.4M | $27.16 |
| 2025 Q3 | UNCHANGED | 6,100,729 | — | 0% | 11.75% | $157.8M | $25.87 |
| 2025 Q2 | REDUCED | 6,100,729 | -399,271 | -6.1% | 13.37% | $124.1M | $20.35 |
| 2025 Q1 | ADDED | 6,500,000 | +1,435,793 | +28.4% | 9.91% | $118.0M | $18.15 |
| 2024 Q4 | ADDED | 5,064,207 | +1,605,598 | +46.4% | 7.56% | $128.0M | $25.27 |
| 2024 Q3 | ADDED | 3,458,609 | +69,642 | +2.1% | 9.01% | $117.6M | $33.99 |
| 2024 Q2 | ADDED | 3,388,967 | +488,967 | +16.9% | 9.67% | $125.4M | $37.01 |
| 2024 Q1 | REDUCED | 2,900,000 | -105,904 | -3.5% | 12.74% | $121.7M | $41.97 |
| 2023 Q4 | REDUCED | 3,005,904 | -194,096 | -6.1% | 13.21% | $119.2M | $39.66 |
| 2023 Q3 | ADDED | 3,200,000 | +600,000 | +23.1% | 14.40% | $88.1M | $27.52 |
As of 2025 Q4 — sorted by position size